News

RBC age doesn’t affect outcomes, trial suggests


 

Blood for transfusion

Photo by Elise Amendola

Results of the RECESS trial suggest the duration of red blood cell (RBC) storage does not affect clinical outcomes in patients undergoing cardiac surgery.

Patients who received older RBCs (stored for 21 days or more) did not have significantly higher multi-organ dysfunction scores, mortality rates, or rates of serious adverse events, when compared to patients who received newer RBCs (stored for 10 days or fewer).

Marie E. Stein, MD, of the University of Minnesota in Minneapolis, and her colleagues reported these results in NEJM. Dr Stein presented the same data last October at the AABB Annual Meeting 2014.

Recommended Reading

Blood products can transmit food allergies
MDedge Hematology and Oncology
Topical TXA decreases use of blood transfusions
MDedge Hematology and Oncology
Storage time doesn’t affect blood quality, study shows
MDedge Hematology and Oncology
Study seems to support liberal transfusion strategy
MDedge Hematology and Oncology
Researchers generate RBCs to treat SCD
MDedge Hematology and Oncology
Polymer can stop lethal bleeding in vivo
MDedge Hematology and Oncology
Plasma product can be stored longer, FDA says
MDedge Hematology and Oncology
ASH advocates use of systems-based hematologists
MDedge Hematology and Oncology
Too many blood tests can lead to anemia, transfusions
MDedge Hematology and Oncology
FDA grants T-cell therapy breakthrough designation
MDedge Hematology and Oncology